Evidence map›Paper›PMID 26669470›Full record

ArticleAmerican journal of respiratory and critical care medicine2015

Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future?

Jonathan A Kropski, William E Lawson, Timothy S Blackwell

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis.American journal of respiratory and critical care medicine · 2016
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jonathan A Kropski1 Department of Medicine Vanderbilt University School of Medicine Nashville, Tennessee.
William E Lawson1 Department of Medicine Vanderbilt University School of Medicine Nashville, Tennessee.
Timothy S Blackwell1 Department of Medicine Vanderbilt University School of Medicine Nashville, Tennessee.

Funding

Mechanisms of Familial Pulmonary FibrosisP01HL092870 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLACKWELL, TIMOTHY S. · 2010 to 2020
$21.6M
Interdisciplinary Training Program in Lung ResearchT32HL094296 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ray Stokes Peebles · 2008 to 2026
$6.3M
Epithelial-Fibroblast Interactions in Lung FibrosisR01HL085317 · NHLBI · VANDERBILT UNIVERSITY · PI BLACKWELL, TIMOTHY S. · 2007 to 2015
$3.5M
Regulation of Fibrotic Remodeling by the Alveolar EpitheliumR01HL105479 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LAWSON, WILLIAM E · 2011 to 2015
$2.2M
NHLBI NIH HHS HL085317NHLBI NIH HHS HL105479NHLBI NIH HHS HL92870NHLBI NIH HHS P01 HL092870NHLBI NIH HHS R01 HL085317NHLBI NIH HHS R01 HL105479NHLBI NIH HHS T32 HL094296
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetylcysteineFemaleHumansIdiopathic Pulmonary FibrosisIntracellular Signaling Peptides and ProteinsMaleMucin-5BAcetylcysteineIntracellular Signaling Peptides and ProteinsMucin-5B

Identifiers

PMID26669470
PMCPMC4731727

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.